探析《时病论》立法特色及雷氏宣透膜原法辨治启迪

doi:10.3969/j.issn.1006-2157.2020.10.002

北京中医药大学学报 ›› 2020, Vol. 43 ›› Issue (10): 804-808.doi: 10.3969/j.issn.1006-2157.2020.10.002

探析《时病论》立法特色及雷氏宣透膜原法辨治启迪

黄婷^1,2, 马慧淼^1,2, 郭延彤^1,2, 程志强^2#

1 北京中医药大学北京 100029;
2 中日友好医院中西医结合肿瘤内科

收稿日期:2020-03-05 出版日期:2020-10-30 发布日期:2020-11-04
通讯作者: #程志强,男,博士,教授,主任医师,博士生导师,主要研究方向:中西医结合治疗肿瘤疾病,E-mail:zhiqiangcheng@163.com
作者简介:黄婷,女,在读硕士生

On therapeutic characteristics of Shibing Lun and application of Lei’s moyuan-diffusing method

Huang Ting^1,2, Ma Huimiao^1,2, Guo Yantong^1,2, Cheng Zhiqiang^2#

1 Beijing University of Chinese Medicine, Beijing 100029, China;
2 Department of Integrative Medicine Oncology, China-Japan Friendship Hospital, Beijing 100029, China

Received:2020-03-05 Online:2020-10-30 Published:2020-11-04
Contact: Prof. Cheng Zhiqiang, MD, Chief Physician, Doctoral Supervisor, China-Japan Friendship Hospital, No.2 East, Yinghua Road, Chaoyang District, Beijing 100029. E-mail: zhiqiangcheng@163.com

摘要/Abstract

摘要： 《时病论》是晚清著名温病学家雷丰博采众方复结合自身临证经验而作的一部时病专著,本文对书中以法代方、会通常变的学术思想及特色进行了研究总结,并深入探析了师于吴又可达原饮之法的雷氏宣透膜原法,从制法背景、证型症状及方药组成等3个方面将二者进行对比,发现该法与本次新型冠状病毒肺炎的辨治多有契合,亦佐证了随机活法乃《时病论》立法的核心。雷氏师古不泥,所拟诸法在理法方药等方面均自有其见解,结合了审因辨病、辨证论治及同病异治、异病同治、活法活用等原则,其会通常变的学术思想不仅对当今医者诊疗思路及临床思维的塑造有着深远影响,对新型冠状病毒肺炎(COVID-19)的诊治亦有一定的借鉴意义,且今已发表文章多证实膜原理论对新冠肺炎的辨治确有启迪,值得深入挖掘研究。

关键词: 时病论, 以法代方, 会通常变, 宣透膜原法, 达原饮, 新型冠状病毒肺炎

Abstract: Shibing Lun (Treatise on Seasonal Diseases) is a monograph on seasonal diseases written by Lei Feng, a famous epidemiologist in the Qing Dynasty. The book recorded experiences of predecessors’ formulas combining with Lei’s own clinical experiences. This paper summarized the academic ideas and characteristics of the monograph, which are stressing therapeutic methods rather than formulas and adapting therapeutic methods according to changing pathogenesis. Furthermore, this paper also analyzed Lei’s moyuan-diffusing method which is based on Wu Youke’s principle of Dayuan Yin (Moyuan-Diffusing Decoction), and made a comparison between the two methods from three aspects, including background of preparation, the symptoms of different patterns, and the composition of prescriptions. It is found that this method is in alignment with the treatment methods used for Corona Virus Disease 2019 (COVID-19), which also proves that adjusting therapeutic methods according to pathogenesis is the key of the theory. Lei learned from the knowledge of the past without being bound by it, and used his own judgement in the treatment. His academic thought not only has far-reaching influences on shaping clinical thinking of doctors today, but can be used for reference in containing the prevalence of COVID-19. Moreover, many published articles have confirmed that moyuan theory is indeed enlightening in the treatment of COVID-19, which deserves further exploration.

Key words: Shibing Lun, therapeutic methods rather than specific prescriptions, adjusting therapeutic methods according to pathogenesis, moyuan-diffusing method, Dayuan Yin, Corona Virus Disease 2019 (COVID-19)

中图分类号:

R254.3

黄婷, 马慧淼, 郭延彤, 程志强. 探析《时病论》立法特色及雷氏宣透膜原法辨治启迪[J]. 北京中医药大学学报, 2020, 43(10): 804-808.

Huang Ting, Ma Huimiao, Guo Yantong, Cheng Zhiqiang. On therapeutic characteristics of Shibing Lun and application of Lei’s moyuan-diffusing method[J]. JOURNAL OF BEIJING UNIVERSITY OF TRADITIONAL CHINESE MEDICINE, 2020, 43(10): 804-808.

参考文献

[1] 邱根祥,许宝才,方昉,等. 衢州雷氏医学源流与学术特色初探[J]. 浙江中医杂志, 2017, 52(11):781-783.
Qiu GX, Xu BC, Fang F, et al. Analysis on the medical origin and academic characteristics of Lei’s medicine in Quzhou[J]. Zhejiang Journal of Traditional Chinese Medicine, 2017,52(11):781-783.
[2] 郑相颖, 郑相敏.《金匮要略》煎药方法探讨[J]. 现代中西医结合杂志, 2010, 19(14):1763-1764.
Zheng XY, Zheng XM. Discussion on decocting methods of Jingui Yaolue[J]. Modern Journal of Integrated Traditional Chinese and Western Medicine, 2010,19(14):1763-1764.
[3] 刘先利, 刘寨华, 刘思鸿,等. 邪伏膜原源流考[J]. 中国中医基础医学杂志, 2016, 22(3):310-311.
Liu XL, Liu ZH, Liu SH, et al. Research on the origin and development of pathogens hidden in moyuan[J]. Journal of Basic Chinese Medicine, 2016, 22(3):310-311.
[4] 徐宁, 徐敬才. 浅析达原饮的运用及其类方[J]. 山东中医药大学学报, 2003, 27(5):341.
Xu N, Xu JC. Analysis on the application of Dayuan Yin and its derivants[J]. Journal of Shandong University of Traditional Chinese Medicine, 2003, 27(5):341.
[5] 杨向东,赵向东,姚伟.《时病论》防治瘟疫方药特色研究[J]. 吉林中医药, 2008, 28(10):772-773.
Yang XD, Zhao XD, Yao W. Study on the characteristics of prescriptions for preventing and treating plague in Shibing Lun[J]. Jilin Journal of Traditional Chinese Medicine, 2008, 28(10):772-773.
[6] 郭晶磊,杨永清.从中国古代大小衡制透视中医古方药物衡值的演变[J]. 科学技术哲学研究, 2019, 36(4):88-93.
Guo JL, Yang YQ. On the evolution of drugs’weight value in prescriptions of traditional Chinese medicine from the perspective of big-scale and small-scale coexisting in Chinese ancient metrology[J]. Studies in Philosophy of Science and Technology, 2019, 36(4):88-93.
[7] 于明坤,柴倩云,梁昌昊,等. 新型冠状病毒肺炎中医预防及诊疗方案汇总分析[J]. 中医杂志, 2020, 61(5):383-387.
Yu MK, Chai QY, Liang CH, et al. An aualysis of the traditional Chinese medicine prevention and treatment interventions for COVID-19[J]. Journal of Traditional Chinese Medicine, 2020, 61(5):383-387.
[8] 邱模炎, 邹浩, 李奇阳, 等. 从新型冠状病毒肺炎现有期刊文献看外感热病的学术争鸣[J]. 福建中医药, 2020, 51(1):11-12.
Qiu MY, Zou H, Li QY, et al. Analysis of academic controversy on externally contracted febrile diseases from existing periodical literature of novel coronavirus pneumonia[J]. Fujian Journal of TCM, 2020, 51(1):11-12.
[9] 黄东晖, 冯淬灵, 蔡俊翔, 等. 111例新型冠状病毒肺炎患者中医辨治临床观察[J]. 北京中医药大学学报, 2020, 43(6):457-462.
Huang DH, Feng CL, Cai JX, et al. Diagnosis and treatment of novel coronavirus pneumonia with traditional Chinese medicine based on clinical observation of 111 cases[J]. Journal of Beijing University of Traditional Chinese Medicine, 2020, 43(6):457-462.
[10] 王玉光,齐文升,马家驹,等.新型冠状病毒肺炎中医临床特征与辨证治疗初探[J].中医杂志,2020,61(4):281-285.
Wang YG, Qi WS, Ma JJ, et al. Clinical features and syndrome differentiation of novel coronavirus pneumonia in traditional Chinese medicine[J]. Journal of Traditional Chinese Medicine, 2020,61(4):281-285.
[11] 张喜奎,朱为坤. 六经辨治新型冠状病毒肺炎探析[J]. 福建中医药, 2020, 51(1):4-5.
Zhang XK, Zhu WK. Analysis of novel coronavirus pneumonia by six channel syndrome differentiation and treatment[J]. Fujian Journal of Traditional Chinese Medicine, 2020, 51(1):4-5.
[12] 国家卫生健康委员会.新型冠状病毒肺炎诊疗方案(试行第七版)[EB/OL]. (2020-03-04) [2020-03-04]. http://www.nhc.gov.cn/yzygj/s7653p/202003/46c9294a7dfe4cef80dc7f5912eb1989.shtml.
National Health Commission of the People's Republic of China. Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (trial version seventh) [EB/OL]. (2020-03-04) [2020-03-04]. http://www.nhc.gov.cn/yzygj/s7653p/202003/46c9294a7dfe4cef80dc7f5912eb1989.shtml.

探析《时病论》立法特色及雷氏宣透膜原法辨治启迪

On therapeutic characteristics of Shibing Lun and application of Lei’s moyuan-diffusing method

PDF (PC)

赞

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 11

Metrics

本文评价

推荐阅读 10

[1]	杨冠男, 姜欣, 谷晓红. 从中医膜系理论探讨新型冠状病毒肺炎的防治策略^*[J]. 北京中医药大学学报, 2020, 43(8): 630-635.
[2]	陈洁, 贾春华. 基于溯因推理的新型冠状病毒肺炎中医病因学探讨[J]. 北京中医药大学学报, 2020, 43(7): 533-538.
[3]	丁霞, 李园, 李萍, 苏泽琦, 吴凤芝, 褚福浩, 谷晓红. 基于关联规则探讨中医药防治新型冠状病毒肺炎协定处方的用药规律^*[J]. 北京中医药大学学报, 2020, 43(6): 449-456.
[4]	黄东晖, 冯淬灵, 蔡俊翔, 王凯源, 谢东平, 冯枫, 宋林, 温敏勇, 王同汉, 张忠德. 111例新型冠状病毒肺炎患者中医辨治临床观察^*[J]. 北京中医药大学学报, 2020, 43(6): 457-462.
[5]	马家驹, 王玉光. 膜原及达原饮的临床指征探析^*[J]. 北京中医药大学学报, 2020, 43(6): 463-468.
[6]	董斐, 柳红良, 谷晓红. 基于“肺—三焦膜原—肾”理论对新型冠状病毒肺炎肺肾同损的认识与思考^*[J]. 北京中医药大学学报, 2020, 43(5): 357-362.
[7]	杨先照, 杜宏波, 赫伟丽, 张敬锋, 刘宁, 崔杰, 陈正光, 杜勇, 叶永安. 新型冠状病毒肺炎恢复期的中医药干预策略^*[J]. 北京中医药大学学报, 2020, 43(5): 363-367.
[8]	王玉光, 程金莲, 闫世艳. 新型冠状病毒肺炎中医临床研究设计存在问题及对策刍议^*[J]. 北京中医药大学学报, 2020, 43(5): 368-372.
[9]	姜欣,徐竞男,高飞,白辰,黄羚,梅沉成,李旖旎,刘铁钢,谷晓红. 柴胡达原饮对大肠杆菌性腹膜炎大鼠血清及腹腔灌洗液TNF-α、IL-10、PGE2的影响^*[J]. 北京中医药大学学报, 2018, 41(12): 983-987.
[10]	张弛, 宋乃光. 《时病论》治咳法的临床应用[J]. 北京中医药大学学报, 2014, 37(9): 589-591.
[11]	张弛宋乃光. 治疫三名方比较研究[J]. 北京中医药大学学报, 2010, 33(08): 514-516.